Skip to content
Screener

Charles River Laboratories CRL Accounts Receivable, Credit Loss Expense (Reversal)

Accounts Receivable, Credit Loss Expense (Reversal) at other companies

Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$13.22B+80.4%
Enterprise value$16.03B+60.9%
P/S3.3×+1.5×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-6%
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:21 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001100682-26-000118
Line itemSix Months Ended / June 27, 2026Six Months Ended / June 28, 2025
Write down of inventories3,16511,067
(Gains) losses and impairments on venture capital and strategic equity investments, net(6,936)12,899
Gain on sale of assets(38,484)
Provision for credit losses1,1242,191
(Gain) loss on divestitures, net181,386(3,376)
Other, net(12,595)2,266
Changes in assets and liabilities:
Trade receivables and contract assets, net(87,135)(18,490)

Item 1. Financial Statements

FAQ

What is Charles River Laboratories's accounts receivable, credit loss expense (reversal)?
Charles River Laboratories (CRL) reported accounts receivable, credit loss expense (reversal) of $1.08M in Q2 2026.
How has Charles River Laboratories's accounts receivable, credit loss expense (reversal) changed year-over-year?
Charles River Laboratories's accounts receivable, credit loss expense (reversal) increased by 485.3% year-over-year, from $184K to $1.08M.
What is the long-term trend for Charles River Laboratories's accounts receivable, credit loss expense (reversal)?
Over 4 years (2021 to 2025), Charles River Laboratories's accounts receivable, credit loss expense (reversal) has grown at a 38.3% compound annual growth rate (CAGR), from $1.66M to $6.06M.
What does accounts receivable, credit loss expense (reversal) mean?
Accounts Receivable, Credit Loss Expense (Reversal)

Ask your AI about Charles River Laboratories's accounts receivable, credit loss expense (reversal).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude